Oral contraceptive use and risk of melanoma in premenopausal women (original) (raw)

References

• Armstrong, BK & English, DR (1996) Cutaneous malignant melanoma. In: Cancer Epidemiology and Prevention, 2nd edn, Schottenfeld D and Fraumeni JF (ed), pp. 1281–1312. Oxford University Press: New York
• Bain, C, Hennekens, CH, Speizer, FE, Rosner, B, Willett, W & Belanger, C (1982) Oral contraceptive use and malignant melanoma. J Natl Cancer Inst 68: 537–539.
  CAS PubMed Google Scholar
• Beral, V, Ramcharan, S & Faris, R (1977) Malignant melanoma and oral contraceptive use among women in California. Br J Cancer 36: 804–809.
  Article CAS Google Scholar
• Beral, V, Evans, S, Shaw, H & Milton, G (1984) Oral contraceptive use and malignant melanoma in Australia. Br J Cancer 50: 681–685.
  Article CAS Google Scholar
• Chaudhuri, PK, Walker, MJ, Briele, HA, Beattie, CW & Das Gupta, TK (1980) Incidence of estrogen receptors in benign nevi and human malignant melanoma. JAMA 244: 791–793.
  Article CAS Google Scholar
• Cocconi, G, Bella, M, Calabresi, F, Tonato, M, Canaletti, R, Boni, C, Buzzi, BG, Corgna, E, Costa, P, Lottici, R, Papadia, F, Sofra, MC & Bacchi, M (1992) Treatment of metastatic malignant melanoma with decarbazine plus tamoxifen. N Engl J Med 327: 517–523.
  Article Google Scholar
• Colditz, GA, Manson, JE & Hankinson, SE (1990) The Nurses’ Health Study: 20-year contribution to the understanding of health among women. J Women Health 6: 49–62.
  Article Google Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 347: 1713–1727.
• D’Agostino, RB, Lee, MLT, Belanger, AJ, Cupples, LA, Anderson, K & Kannel, WB (1990) Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med 9: 1501–1515.
  Article Google Scholar
• DerSimonian, R & Laird, N (1986) Meta-analysis in clinical trials. Controlled Clin Trials 7: 177–188.
  Article CAS Google Scholar
• Fisher, RI, Heifeld, JP & Lippman, ME (1976) Oestrogen receptors in human malignant melanoma. Lancet 2: 337–339.
  Article CAS Google Scholar
• Gallagher, RP, Elwood, JM, Hill, GB, Coldman, AJ, Threlfall, WJ & Spinelli, JJ (1985) Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada melanoma study. Br J Cancer 52: 901–907.
  Article CAS Google Scholar
• Hannaford, PC, Villard-Mackintosh, L, Vessey, MP & Kay, CR (1991) Oral contraceptives and malignant melanoma. Br J Cancer 63: 430–433.
  Article CAS Google Scholar
• Helmrich, SP, Rosenberg, L, Kaufman, DW, Miller, DR, Schottenfeld, D, Stolley, PD & Shapiro, S (1984) Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use. J Natl Cancer Inst 72: 617–620.
  CAS PubMed Google Scholar
• Holly, EA, Weiss, NS & Liff, JM (1983) Cutaneous melanoma in relation to exogenous hormones and reproductive factors. J Natl Cancer Inst 70: 827–831.
  CAS PubMed Google Scholar
• Holly, EA, Cress, RD & Ahn, DK (1995) Cutaneous melanoma in women: reproductive factors and oral contraceptive use. Am J Epidemiol 141: 943–950.
  Article CAS Google Scholar
• Holman, CDJ, Armstrong, BK & Heenan, PJ (1984) Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer 50: 673–680.
  Article CAS Google Scholar
• Holman, CDJ, Armstrong, BK & Heenan, PJ (1986) Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 76: 403–414.
  CAS PubMed Google Scholar
• Hunter, DJ, Manson, JE, Colditz, GA, Chasan-Taber, L, Troy, L, Stampfer, MJ, Speizer, FE & Willett, WC (1997) Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women. Contraception 56: 373–378.
  Article CAS Google Scholar
• Jelinek, JE (1970) Cutaneous side effects of oral contraceptive. Arch Dermatol 101: 181–186.
  Article CAS Google Scholar
• Le, MG, Cabanes, PA, Desvignes, V, Chanteau, MF, Mlika, N & Avril, MF (1992) Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women. Cancer Causes Control 3: 199–205.
  Article CAS Google Scholar
• Liu, T & Soong, S-J (1996) Epidemiology of malignant melanoma. Surgical Clinics N Amer 76: 1205–1221.
  Article CAS Google Scholar
• MacKie, RM, Freudenberger, T & Aitchison, TC (1989) Personal risk-factor chart for cutaneous melanoma. Lancet 2: 487–490.
  Article CAS Google Scholar
• McCarty, KS Jr, Wortman, J, Stowers, S, Lubahn, DB, McCarty, KS Sr & Seigler, HF (1980) Sex steroid receptor analysis in human melanoma. Cancer 46: 1463–1470.
  Article Google Scholar
• McClay, EF, Mastrangelo, MJ, Berd, D & Bellet, RE (1992) Effective combination chemo/hormonal therapy for malignant melanoma: experience with three consecutive trials. Int J Cancer 50: 553–556.
  Article CAS Google Scholar
• McClay, EF, Albright, KD, Jones, JA, Christian, RD & Howell, SB (1993) Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cells. Cancer Res 53: 1571–1576.
  CAS Google Scholar
• Mirimanoff, RO, Wagenknecht, L & Hunziger, N (1981) Long-term complete remission of malignant melanoma with tamoxifen. Lancet 1: 1368–1369.
  Article CAS Google Scholar
• Nesbit, RA, Woods, RL, Tattersall, MH, Tox, RM, Forbes, JF, MacKay, IR & Goodyear, M (1979) Tamoxifen in malignant melanoma [letter]. N Engl J Med 301: 1241–1242.
  CAS PubMed Google Scholar
• Osterlind, A, Tucker, MA, Stone, BJ & Jensen, OM (1988a) The Danish case–control study of cutaneous malignant melanoma. II. Importance of UV-light exposure. Int J Cancer 42: 319–324.
  Article CAS Google Scholar
• Osterlind, A, Tucker, MA, Stone, BJ & Jensen, OM (1988b) The Danish case–control study of cutaneous malignant melanoma: hormonal and reproductive factors in women. Int J Cancer 42: 821–824.
  Article CAS Google Scholar
• Palmer, JR, Rosenberg, L, Stron, BL, Harlap, S, Zauber, AG, Warchauer, ME & Shapiro, S (1992) Oral contraceptive use and risk of cutaneous malignant melanoma. Cancer Causes Control 3: 547–554.
  Article CAS Google Scholar
• Ramcharan, S, Pellegrin, FA, Ray, R & Hsu, JP (1981). The Walnut Creek Contraceptive Drug Study, Vol. III. NIH Publication No 81–564. US Government Printing Office: Washington, DC
• Snell, RS & Bischitz, PG (1960) The effect of large doses of estrogen and estrogen and progesterone on melanin pigmentation. J Invest Dermatol 35: 73–82.
  Article CAS Google Scholar
• Telhaug, R, Klepp, O & Bormer, O (1982) Phase II study of tamoxifen in patients with metastatic malignant melanoma. Cancer Treat Rep 66: 1437
  CAS PubMed Google Scholar
• Wagstaff, J, Thatcher, N, Rankin, E & Crowther, D (1982) Tamoxifen in the treatment of metastatic malignant melanoma. Cancer Treat Rep 66: 1771
  CAS PubMed Google Scholar
• Weinstock, MA, Colditz, GA, Willett, WC, Stampfer, MC, Bronstein, BR, Mihm, MC & Speizer, FE (1989) Non-familial cutaneous melanoma incidence in women associated with sun exposure before 20 years of age. Pediatrics 84: 199–204.
  CAS PubMed Google Scholar
• Westerdahl, J, Olsson, H, Masback, A, Ingvar, C & Johsson, N (1996) Risk of malignant melanoma in relation to drug intake, alcohol, smoking, and hormonal factors. Br J Cancer 73: 1126–1131.
  Article CAS Google Scholar
• Zanetti, R, Franceschi, S, Rosso, S, Bidoli, E & Colonna, S (1990) Cutaneous malignant melanoma in females: the role of hormonal and reproductive factors. Int J Epidemiol 19: 522–526.
  Article CAS Google Scholar

Download references